

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.94933508 |
| 2 | synaptic vesicle exocytosis (GO:0016079) | 4.92879790 |
| 3 | vocalization behavior (GO:0071625) | 4.87551085 |
| 4 | neuron cell-cell adhesion (GO:0007158) | 4.75315655 |
| 5 | neuronal action potential propagation (GO:0019227) | 4.57319123 |
| 6 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.54010609 |
| 7 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.53492630 |
| 8 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.37219270 |
| 9 | neurotransmitter secretion (GO:0007269) | 4.20510451 |
| 10 | regulation of synaptic vesicle transport (GO:1902803) | 4.08678289 |
| 11 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 4.00959619 |
| 12 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.95279513 |
| 13 | auditory behavior (GO:0031223) | 3.93623609 |
| 14 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.92801924 |
| 15 | synaptic vesicle maturation (GO:0016188) | 3.92563197 |
| 16 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.91459720 |
| 17 | nucleobase catabolic process (GO:0046113) | 3.86935206 |
| 18 | response to auditory stimulus (GO:0010996) | 3.86461020 |
| 19 | protein localization to synapse (GO:0035418) | 3.85339807 |
| 20 | startle response (GO:0001964) | 3.82241322 |
| 21 | locomotory exploration behavior (GO:0035641) | 3.81872089 |
| 22 | cellular potassium ion homeostasis (GO:0030007) | 3.73284285 |
| 23 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.72163199 |
| 24 | regulation of synapse structural plasticity (GO:0051823) | 3.69437649 |
| 25 | response to pheromone (GO:0019236) | 3.62977309 |
| 26 | C4-dicarboxylate transport (GO:0015740) | 3.58672655 |
| 27 | glutamate secretion (GO:0014047) | 3.52800041 |
| 28 | gamma-aminobutyric acid transport (GO:0015812) | 3.48570059 |
| 29 | negative regulation of catecholamine secretion (GO:0033604) | 3.46877437 |
| 30 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.46449894 |
| 31 | neurotransmitter transport (GO:0006836) | 3.42546583 |
| 32 | postsynaptic membrane organization (GO:0001941) | 3.40551884 |
| 33 | neurofilament cytoskeleton organization (GO:0060052) | 3.40202920 |
| 34 | presynaptic membrane assembly (GO:0097105) | 3.39681696 |
| 35 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.38738818 |
| 36 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.36872534 |
| 37 | behavioral response to nicotine (GO:0035095) | 3.36362954 |
| 38 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.34529387 |
| 39 | righting reflex (GO:0060013) | 3.33712909 |
| 40 | mechanosensory behavior (GO:0007638) | 3.32786035 |
| 41 | neuromuscular process controlling posture (GO:0050884) | 3.31597597 |
| 42 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.28323450 |
| 43 | synaptic transmission, glutamatergic (GO:0035249) | 3.25692636 |
| 44 | insulin secretion (GO:0030073) | 3.25128619 |
| 45 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.24660080 |
| 46 | neuron-neuron synaptic transmission (GO:0007270) | 3.23975803 |
| 47 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.21445052 |
| 48 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.19028424 |
| 49 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.18257581 |
| 50 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.18201786 |
| 51 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.18201786 |
| 52 | adult walking behavior (GO:0007628) | 3.17872198 |
| 53 | regulation of respiratory system process (GO:0044065) | 3.17818983 |
| 54 | exploration behavior (GO:0035640) | 3.17355796 |
| 55 | glycosphingolipid biosynthetic process (GO:0006688) | 3.17184906 |
| 56 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.14435065 |
| 57 | neuron recognition (GO:0008038) | 3.14362766 |
| 58 | establishment of mitochondrion localization (GO:0051654) | 3.14219605 |
| 59 | presynaptic membrane organization (GO:0097090) | 3.13978780 |
| 60 | regulation of penile erection (GO:0060405) | 3.13767573 |
| 61 | central nervous system myelination (GO:0022010) | 3.13577940 |
| 62 | axon ensheathment in central nervous system (GO:0032291) | 3.13577940 |
| 63 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.13532406 |
| 64 | proline transport (GO:0015824) | 3.13453165 |
| 65 | regulation of vesicle fusion (GO:0031338) | 3.10851565 |
| 66 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.10515767 |
| 67 | * detection of calcium ion (GO:0005513) | 3.08166605 |
| 68 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.07628721 |
| 69 | potassium ion homeostasis (GO:0055075) | 3.07196693 |
| 70 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.07196055 |
| 71 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.06867031 |
| 72 | transmission of nerve impulse (GO:0019226) | 3.05436185 |
| 73 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 3.02741602 |
| 74 | synapse organization (GO:0050808) | 3.01632042 |
| 75 | glutamate receptor signaling pathway (GO:0007215) | 3.01375073 |
| 76 | regulation of neurotransmitter levels (GO:0001505) | 3.00031705 |
| 77 | positive regulation of membrane potential (GO:0045838) | 2.99956701 |
| 78 | cerebellar Purkinje cell layer development (GO:0021680) | 2.98407693 |
| 79 | positive regulation of synapse assembly (GO:0051965) | 2.97897255 |
| 80 | synapse assembly (GO:0007416) | 2.97545634 |
| 81 | signal release (GO:0023061) | 2.93609656 |
| 82 | transferrin transport (GO:0033572) | 2.92594508 |
| 83 | negative regulation of dendrite development (GO:2000171) | 2.92267863 |
| 84 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.91494640 |
| 85 | layer formation in cerebral cortex (GO:0021819) | 2.89369661 |
| 86 | positive regulation of dendritic spine development (GO:0060999) | 2.88230036 |
| 87 | potassium ion import (GO:0010107) | 2.87844071 |
| 88 | membrane hyperpolarization (GO:0060081) | 2.87205450 |
| 89 | activation of protein kinase A activity (GO:0034199) | 2.87200105 |
| 90 | sodium ion export (GO:0071436) | 2.86663442 |
| 91 | synaptic transmission, cholinergic (GO:0007271) | 2.85814605 |
| 92 | dendrite morphogenesis (GO:0048813) | 2.85277321 |
| 93 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.85033770 |
| 94 | neuromuscular synaptic transmission (GO:0007274) | 2.85008302 |
| 95 | synaptic vesicle transport (GO:0048489) | 2.84346117 |
| 96 | establishment of synaptic vesicle localization (GO:0097480) | 2.84346117 |
| 97 | cerebellar granule cell differentiation (GO:0021707) | 2.84251895 |
| 98 | behavioral response to ethanol (GO:0048149) | 2.83135863 |
| 99 | short-term memory (GO:0007614) | 2.82503761 |
| 100 | COPI coating of Golgi vesicle (GO:0048205) | 2.81697768 |
| 101 | Golgi transport vesicle coating (GO:0048200) | 2.81697768 |
| 102 | positive regulation of synapse maturation (GO:0090129) | 2.81492238 |
| 103 | regulation of neurotransmitter transport (GO:0051588) | 2.81260602 |
| 104 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.80177037 |
| 105 | synaptic vesicle endocytosis (GO:0048488) | 2.79647075 |
| 106 | ferric iron transport (GO:0015682) | 2.79279896 |
| 107 | trivalent inorganic cation transport (GO:0072512) | 2.79279896 |
| 108 | negative regulation of norepinephrine secretion (GO:0010700) | 2.78832281 |
| 109 | ER overload response (GO:0006983) | 2.78327148 |
| 110 | glycerophospholipid catabolic process (GO:0046475) | 2.78226425 |
| 111 | membrane depolarization (GO:0051899) | 2.77603440 |
| 112 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.76783686 |
| 113 | long-term memory (GO:0007616) | 2.76543457 |
| 114 | L-amino acid import (GO:0043092) | 2.76270568 |
| 115 | regulation of exocytosis (GO:0017157) | 2.75640084 |
| 116 | long-term synaptic potentiation (GO:0060291) | 2.75347404 |
| 117 | adaptation of signaling pathway (GO:0023058) | 2.75189526 |
| 118 | acidic amino acid transport (GO:0015800) | 2.75080997 |
| 119 | succinate metabolic process (GO:0006105) | 2.74550835 |
| 120 | calcium ion-dependent exocytosis (GO:0017156) | 2.74392201 |
| 121 | adult behavior (GO:0030534) | 2.72900928 |
| 122 | neurotransmitter uptake (GO:0001504) | 2.72894840 |
| 123 | regulation of neurotransmitter uptake (GO:0051580) | 2.72285147 |
| 124 | axonal fasciculation (GO:0007413) | 2.71844978 |
| 125 | positive regulation of amino acid transport (GO:0051957) | 2.70766012 |
| 126 | dendritic spine morphogenesis (GO:0060997) | 2.70271619 |
| 127 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.69466093 |
| 128 | neuronal ion channel clustering (GO:0045161) | 2.69455158 |
| 129 | regulation of neurotransmitter secretion (GO:0046928) | 2.69296460 |
| 130 | striatum development (GO:0021756) | 2.68094427 |
| 131 | negative regulation of amine transport (GO:0051953) | 2.68016399 |
| 132 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.66845896 |
| 133 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.66587295 |
| 134 | regulation of glucocorticoid secretion (GO:2000849) | 2.66078953 |
| 135 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.65707744 |
| 136 | establishment of vesicle localization (GO:0051650) | 2.65423030 |
| 137 | membrane depolarization during action potential (GO:0086010) | 2.65171678 |
| 138 | regulation of synapse assembly (GO:0051963) | 2.64738026 |
| 139 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.64261296 |
| 140 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.63300792 |
| 141 | cell communication by electrical coupling (GO:0010644) | 2.63128410 |
| 142 | regulation of postsynaptic membrane potential (GO:0060078) | 2.61227751 |
| 143 | positive regulation of exocytosis (GO:0045921) | 2.60818532 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * EZH2_22144423_ChIP-Seq_EOC_Human | 5.71929804 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.95026496 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.89292936 |
| 4 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.80653266 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.73731234 |
| 6 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.71246628 |
| 7 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.49992376 |
| 8 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.43668899 |
| 9 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.41861476 |
| 10 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.37628232 |
| 11 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.35135588 |
| 12 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.34786203 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.28502582 |
| 14 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.26383709 |
| 15 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.25964432 |
| 16 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.25964432 |
| 17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.24788067 |
| 18 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.22111722 |
| 19 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.14299400 |
| 20 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.13224436 |
| 21 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.12631857 |
| 22 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.10582499 |
| 23 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.08185084 |
| 24 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.06578063 |
| 25 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.03714497 |
| 26 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.03181459 |
| 27 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.98602371 |
| 28 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.98390705 |
| 29 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.90651293 |
| 30 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.90090024 |
| 31 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.82158428 |
| 32 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.78452969 |
| 33 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.76413353 |
| 34 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.71190996 |
| 35 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.70783108 |
| 36 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.68202247 |
| 37 | P300_19829295_ChIP-Seq_ESCs_Human | 1.65805317 |
| 38 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.64818911 |
| 39 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.54779429 |
| 40 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.54222679 |
| 41 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.53803369 |
| 42 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.52981939 |
| 43 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.52690231 |
| 44 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.51520660 |
| 45 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.48472288 |
| 46 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.47255664 |
| 47 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.46885494 |
| 48 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.46407403 |
| 49 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.44866492 |
| 50 | VDR_22108803_ChIP-Seq_LS180_Human | 1.39279748 |
| 51 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.39087051 |
| 52 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.38485084 |
| 53 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.38071599 |
| 54 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.36558100 |
| 55 | STAT3_23295773_ChIP-Seq_U87_Human | 1.35959909 |
| 56 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.34424605 |
| 57 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.34322681 |
| 58 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.33422236 |
| 59 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.30792721 |
| 60 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.28468427 |
| 61 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.22654433 |
| 62 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.20975057 |
| 63 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20594039 |
| 64 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.15992901 |
| 65 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.15273504 |
| 66 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.14998861 |
| 67 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.14534884 |
| 68 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.13431298 |
| 69 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.12819464 |
| 70 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.12768251 |
| 71 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.12251055 |
| 72 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.12206370 |
| 73 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10998496 |
| 74 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.10767799 |
| 75 | * AR_19668381_ChIP-Seq_PC3_Human | 1.10514535 |
| 76 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10442178 |
| 77 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.10119105 |
| 78 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.09817402 |
| 79 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.08376268 |
| 80 | FUS_26573619_Chip-Seq_HEK293_Human | 1.07406726 |
| 81 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.05801484 |
| 82 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.05753745 |
| 83 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.04519817 |
| 84 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.02226290 |
| 85 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.01963029 |
| 86 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.00251170 |
| 87 | * KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.99601555 |
| 88 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.98825748 |
| 89 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.97526778 |
| 90 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.97519545 |
| 91 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.96474129 |
| 92 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.96066275 |
| 93 | * JUN_21703547_ChIP-Seq_K562_Human | 0.95789835 |
| 94 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.94424807 |
| 95 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.94315694 |
| 96 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94182368 |
| 97 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93938432 |
| 98 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.93938432 |
| 99 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.92423873 |
| 100 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.92065636 |
| 101 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.91688777 |
| 102 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.91579796 |
| 103 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.91329391 |
| 104 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.90944488 |
| 105 | * KDM2B_26808549_Chip-Seq_REH_Human | 0.90872519 |
| 106 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.90460509 |
| 107 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.90025492 |
| 108 | * REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.89864803 |
| 109 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.88501573 |
| 110 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.87900775 |
| 111 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.87843413 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 3.55041482 |
| 2 | MP0003880_abnormal_central_pattern | 3.30486241 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.24891154 |
| 4 | MP0005645_abnormal_hypothalamus_physiol | 2.89671951 |
| 5 | MP0010386_abnormal_urinary_bladder | 2.85530791 |
| 6 | MP0004270_analgesia | 2.83956568 |
| 7 | MP0006276_abnormal_autonomic_nervous | 2.81422933 |
| 8 | MP0009780_abnormal_chondrocyte_physiolo | 2.76827975 |
| 9 | MP0009046_muscle_twitch | 2.73312141 |
| 10 | MP0003122_maternal_imprinting | 2.62549474 |
| 11 | MP0002064_seizures | 2.60690631 |
| 12 | MP0009745_abnormal_behavioral_response | 2.59202345 |
| 13 | MP0002063_abnormal_learning/memory/cond | 2.52903960 |
| 14 | MP0000013_abnormal_adipose_tissue | 2.46394667 |
| 15 | MP0002837_dystrophic_cardiac_calcinosis | 2.42098677 |
| 16 | MP0002734_abnormal_mechanical_nocicepti | 2.41805499 |
| 17 | MP0005646_abnormal_pituitary_gland | 2.38094007 |
| 18 | MP0004043_abnormal_pH_regulation | 2.37926005 |
| 19 | MP0002909_abnormal_adrenal_gland | 2.37644989 |
| 20 | MP0002572_abnormal_emotion/affect_behav | 2.35527680 |
| 21 | MP0002735_abnormal_chemical_nociception | 2.32756302 |
| 22 | MP0005423_abnormal_somatic_nervous | 2.29568084 |
| 23 | MP0002272_abnormal_nervous_system | 2.29512008 |
| 24 | MP0001968_abnormal_touch/_nociception | 2.17813913 |
| 25 | MP0002822_catalepsy | 2.01679312 |
| 26 | MP0002733_abnormal_thermal_nociception | 1.99645874 |
| 27 | MP0001986_abnormal_taste_sensitivity | 1.97962731 |
| 28 | MP0003283_abnormal_digestive_organ | 1.97016188 |
| 29 | MP0001188_hyperpigmentation | 1.96965575 |
| 30 | MP0001486_abnormal_startle_reflex | 1.96481686 |
| 31 | MP0002184_abnormal_innervation | 1.96324782 |
| 32 | MP0001501_abnormal_sleep_pattern | 1.87628944 |
| 33 | MP0001970_abnormal_pain_threshold | 1.86976629 |
| 34 | MP0001984_abnormal_olfaction | 1.85738352 |
| 35 | MP0002557_abnormal_social/conspecific_i | 1.83511441 |
| 36 | MP0002067_abnormal_sensory_capabilities | 1.81339126 |
| 37 | MP0002638_abnormal_pupillary_reflex | 1.80962354 |
| 38 | MP0001440_abnormal_grooming_behavior | 1.77822493 |
| 39 | MP0005379_endocrine/exocrine_gland_phen | 1.75438669 |
| 40 | MP0001502_abnormal_circadian_rhythm | 1.68888395 |
| 41 | MP0004142_abnormal_muscle_tone | 1.65945576 |
| 42 | MP0003787_abnormal_imprinting | 1.64888327 |
| 43 | MP0003183_abnormal_peptide_metabolism | 1.60600116 |
| 44 | MP0002693_abnormal_pancreas_physiology | 1.56020242 |
| 45 | MP0008569_lethality_at_weaning | 1.53087113 |
| 46 | MP0002736_abnormal_nociception_after | 1.50464531 |
| 47 | MP0006072_abnormal_retinal_apoptosis | 1.49379560 |
| 48 | MP0000955_abnormal_spinal_cord | 1.49124365 |
| 49 | MP0002876_abnormal_thyroid_physiology | 1.47373148 |
| 50 | MP0005386_behavior/neurological_phenoty | 1.45957281 |
| 51 | MP0004924_abnormal_behavior | 1.45957281 |
| 52 | MP0001529_abnormal_vocalization | 1.42030698 |
| 53 | MP0008877_abnormal_DNA_methylation | 1.40576849 |
| 54 | MP0001944_abnormal_pancreas_morphology | 1.37230518 |
| 55 | MP0000778_abnormal_nervous_system | 1.37195331 |
| 56 | MP0003879_abnormal_hair_cell | 1.33310819 |
| 57 | MP0004811_abnormal_neuron_physiology | 1.29603274 |
| 58 | MP0001485_abnormal_pinna_reflex | 1.24235104 |
| 59 | MP0002066_abnormal_motor_capabilities/c | 1.23576731 |
| 60 | MP0002882_abnormal_neuron_morphology | 1.22869258 |
| 61 | MP0000631_abnormal_neuroendocrine_gland | 1.21143441 |
| 62 | MP0002877_abnormal_melanocyte_morpholog | 1.16468307 |
| 63 | MP0003121_genomic_imprinting | 1.14693492 |
| 64 | MP0004858_abnormal_nervous_system | 1.14471924 |
| 65 | MP0000678_abnormal_parathyroid_gland | 1.09352238 |
| 66 | MP0002163_abnormal_gland_morphology | 1.04583917 |
| 67 | MP0004133_heterotaxia | 1.03869448 |
| 68 | MP0004885_abnormal_endolymph | 1.02850049 |
| 69 | MP0002078_abnormal_glucose_homeostasis | 1.02597245 |
| 70 | MP0005551_abnormal_eye_electrophysiolog | 0.99925894 |
| 71 | MP0002069_abnormal_eating/drinking_beha | 0.99544227 |
| 72 | MP0002229_neurodegeneration | 0.99497395 |
| 73 | MP0003690_abnormal_glial_cell | 0.97640416 |
| 74 | MP0004742_abnormal_vestibular_system | 0.96203067 |
| 75 | MP0002653_abnormal_ependyma_morphology | 0.95510988 |
| 76 | MP0003329_amyloid_beta_deposits | 0.95252320 |
| 77 | MP0005535_abnormal_body_temperature | 0.92709933 |
| 78 | MP0000569_abnormal_digit_pigmentation | 0.91916495 |
| 79 | MP0003136_yellow_coat_color | 0.91394061 |
| 80 | MP0003195_calcinosis | 0.88763087 |
| 81 | MP0003123_paternal_imprinting | 0.87739483 |
| 82 | MP0002152_abnormal_brain_morphology | 0.84675752 |
| 83 | MP0003938_abnormal_ear_development | 0.84067798 |
| 84 | MP0003632_abnormal_nervous_system | 0.84023427 |
| 85 | MP0002234_abnormal_pharynx_morphology | 0.83598090 |
| 86 | MP0003011_delayed_dark_adaptation | 0.83453118 |
| 87 | MP0001963_abnormal_hearing_physiology | 0.83152348 |
| 88 | MP0002102_abnormal_ear_morphology | 0.81898753 |
| 89 | MP0006292_abnormal_olfactory_placode | 0.81456977 |
| 90 | MP0004085_abnormal_heartbeat | 0.81441809 |
| 91 | MP0005253_abnormal_eye_physiology | 0.80933944 |
| 92 | MP0004147_increased_porphyrin_level | 0.80863763 |
| 93 | MP0000566_synostosis | 0.79937998 |
| 94 | MP0003633_abnormal_nervous_system | 0.79836781 |
| 95 | MP0000003_abnormal_adipose_tissue | 0.79520108 |
| 96 | MP0005171_absent_coat_pigmentation | 0.78807819 |
| 97 | MP0003953_abnormal_hormone_level | 0.78740187 |
| 98 | MP0008961_abnormal_basal_metabolism | 0.78426692 |
| 99 | MP0003634_abnormal_glial_cell | 0.77656453 |
| 100 | MP0003861_abnormal_nervous_system | 0.76318271 |
| 101 | MP0000920_abnormal_myelination | 0.75333370 |
| 102 | MP0001664_abnormal_digestion | 0.73930308 |
| 103 | MP0003172_abnormal_lysosome_physiology | 0.73048695 |
| 104 | MP0001905_abnormal_dopamine_level | 0.72682687 |
| 105 | MP0003137_abnormal_impulse_conducting | 0.72441261 |
| 106 | MP0002752_abnormal_somatic_nervous | 0.70917988 |
| 107 | MP0001765_abnormal_ion_homeostasis | 0.70099392 |
| 108 | MP0005195_abnormal_posterior_eye | 0.69639050 |
| 109 | MP0001299_abnormal_eye_distance/ | 0.69440428 |
| 110 | MP0001270_distended_abdomen | 0.67958967 |
| 111 | MP0005448_abnormal_energy_balance | 0.67753032 |
| 112 | MP0005248_abnormal_Harderian_gland | 0.66957733 |
| 113 | MP0002751_abnormal_autonomic_nervous | 0.65473151 |
| 114 | MP0003890_abnormal_embryonic-extraembry | 0.65269823 |
| 115 | MP0000015_abnormal_ear_pigmentation | 0.65247378 |
| 116 | MP0002938_white_spotting | 0.64378717 |
| 117 | MP0003119_abnormal_digestive_system | 0.63950650 |
| 118 | MP0008789_abnormal_olfactory_epithelium | 0.63328754 |
| 119 | MP0005499_abnormal_olfactory_system | 0.61446321 |
| 120 | MP0005394_taste/olfaction_phenotype | 0.61446321 |
| 121 | MP0000026_abnormal_inner_ear | 0.60849965 |
| 122 | MP0003631_nervous_system_phenotype | 0.60647711 |
| 123 | MP0001177_atelectasis | 0.60610733 |
| 124 | MP0003959_abnormal_lean_body | 0.59449775 |
| 125 | MP0004145_abnormal_muscle_electrophysio | 0.59281461 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.28631228 |
| 2 | Atonic seizures (HP:0010819) | 5.02185633 |
| 3 | Febrile seizures (HP:0002373) | 4.66563796 |
| 4 | Visual hallucinations (HP:0002367) | 4.48238914 |
| 5 | Focal seizures (HP:0007359) | 4.16518658 |
| 6 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.92080430 |
| 7 | Absence seizures (HP:0002121) | 3.91912702 |
| 8 | Progressive cerebellar ataxia (HP:0002073) | 3.82651112 |
| 9 | Epileptic encephalopathy (HP:0200134) | 3.81339032 |
| 10 | Myokymia (HP:0002411) | 3.67724111 |
| 11 | Abnormality of the corticospinal tract (HP:0002492) | 3.63632859 |
| 12 | Dialeptic seizures (HP:0011146) | 3.46398189 |
| 13 | Decreased circulating renin level (HP:0003351) | 3.43319245 |
| 14 | Hyperventilation (HP:0002883) | 3.42743574 |
| 15 | Pheochromocytoma (HP:0002666) | 3.38824691 |
| 16 | Agitation (HP:0000713) | 3.33688117 |
| 17 | Generalized tonic-clonic seizures (HP:0002069) | 3.28765580 |
| 18 | Failure to thrive in infancy (HP:0001531) | 3.26651558 |
| 19 | Hypoglycemic seizures (HP:0002173) | 3.23429822 |
| 20 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.19059636 |
| 21 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.19059636 |
| 22 | Neuroendocrine neoplasm (HP:0100634) | 3.14240404 |
| 23 | Gait imbalance (HP:0002141) | 3.13024319 |
| 24 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.09878143 |
| 25 | Symptomatic seizures (HP:0011145) | 2.98811456 |
| 26 | Hemiplegia (HP:0002301) | 2.96902957 |
| 27 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.84988506 |
| 28 | Polyphagia (HP:0002591) | 2.83729371 |
| 29 | EEG with generalized epileptiform discharges (HP:0011198) | 2.83478222 |
| 30 | Congenital primary aphakia (HP:0007707) | 2.81562060 |
| 31 | Epileptiform EEG discharges (HP:0011182) | 2.80857569 |
| 32 | Abnormal hair whorl (HP:0010721) | 2.80545716 |
| 33 | Medial flaring of the eyebrow (HP:0010747) | 2.74660998 |
| 34 | Hypsarrhythmia (HP:0002521) | 2.73546636 |
| 35 | Oligomenorrhea (HP:0000876) | 2.67865108 |
| 36 | Nephrogenic diabetes insipidus (HP:0009806) | 2.65772832 |
| 37 | Intention tremor (HP:0002080) | 2.63423422 |
| 38 | Status epilepticus (HP:0002133) | 2.61628106 |
| 39 | Anxiety (HP:0000739) | 2.57049259 |
| 40 | Hypothermia (HP:0002045) | 2.53268573 |
| 41 | Abnormal eating behavior (HP:0100738) | 2.52676940 |
| 42 | Truncal ataxia (HP:0002078) | 2.52463227 |
| 43 | Spastic gait (HP:0002064) | 2.47580583 |
| 44 | Urinary urgency (HP:0000012) | 2.46192767 |
| 45 | Poor suck (HP:0002033) | 2.46149536 |
| 46 | Hepatoblastoma (HP:0002884) | 2.44433227 |
| 47 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.43850341 |
| 48 | Progressive inability to walk (HP:0002505) | 2.40938764 |
| 49 | Absent speech (HP:0001344) | 2.36396188 |
| 50 | Action tremor (HP:0002345) | 2.32626159 |
| 51 | Depression (HP:0000716) | 2.31883903 |
| 52 | Hyperactive renin-angiotensin system (HP:0000841) | 2.30272715 |
| 53 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.29920115 |
| 54 | Vaginal atresia (HP:0000148) | 2.25079619 |
| 55 | Genital tract atresia (HP:0001827) | 2.24248397 |
| 56 | Supranuclear gaze palsy (HP:0000605) | 2.24118957 |
| 57 | Limb dystonia (HP:0002451) | 2.22444395 |
| 58 | Abnormality of the labia minora (HP:0012880) | 2.22400514 |
| 59 | Gaze-evoked nystagmus (HP:0000640) | 2.19098290 |
| 60 | Hyperglycemia (HP:0003074) | 2.18510855 |
| 61 | Acute necrotizing encephalopathy (HP:0006965) | 2.16159449 |
| 62 | Dysdiadochokinesis (HP:0002075) | 2.14340804 |
| 63 | Specific learning disability (HP:0001328) | 2.13010332 |
| 64 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.11258871 |
| 65 | Blue irides (HP:0000635) | 2.11160104 |
| 66 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.10964011 |
| 67 | Oligodactyly (hands) (HP:0001180) | 2.09161229 |
| 68 | Impaired vibratory sensation (HP:0002495) | 2.08656236 |
| 69 | Aplasia/Hypoplasia of the lens (HP:0008063) | 2.08126387 |
| 70 | Lissencephaly (HP:0001339) | 2.05963066 |
| 71 | Torticollis (HP:0000473) | 2.05691963 |
| 72 | Ankle clonus (HP:0011448) | 2.05631813 |
| 73 | Abnormality of renin-angiotensin system (HP:0000847) | 2.03572117 |
| 74 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.03437571 |
| 75 | Ulnar claw (HP:0001178) | 2.03338014 |
| 76 | Pachygyria (HP:0001302) | 2.03337813 |
| 77 | Abnormal social behavior (HP:0012433) | 2.03318704 |
| 78 | Impaired social interactions (HP:0000735) | 2.03318704 |
| 79 | Protruding tongue (HP:0010808) | 2.02529982 |
| 80 | Progressive macrocephaly (HP:0004481) | 2.01912449 |
| 81 | Excessive salivation (HP:0003781) | 2.01698309 |
| 82 | Drooling (HP:0002307) | 2.01698309 |
| 83 | Cortical visual impairment (HP:0100704) | 2.00895627 |
| 84 | Broad-based gait (HP:0002136) | 1.99714387 |
| 85 | Generalized myoclonic seizures (HP:0002123) | 1.98068201 |
| 86 | Hemiparesis (HP:0001269) | 1.96548766 |
| 87 | Absent eyebrow (HP:0002223) | 1.96185907 |
| 88 | Poor eye contact (HP:0000817) | 1.95676996 |
| 89 | Diplopia (HP:0000651) | 1.95240816 |
| 90 | Abnormality of binocular vision (HP:0011514) | 1.95240816 |
| 91 | Poor coordination (HP:0002370) | 1.92877391 |
| 92 | Abnormal drinking behavior (HP:0030082) | 1.92060404 |
| 93 | Polydipsia (HP:0001959) | 1.92060404 |
| 94 | Amyotrophic lateral sclerosis (HP:0007354) | 1.91988113 |
| 95 | Amblyopia (HP:0000646) | 1.91268434 |
| 96 | Papilledema (HP:0001085) | 1.91113540 |
| 97 | Nephronophthisis (HP:0000090) | 1.90069230 |
| 98 | Esotropia (HP:0000565) | 1.88863656 |
| 99 | Mutism (HP:0002300) | 1.88548599 |
| 100 | Narrow nasal bridge (HP:0000446) | 1.88505306 |
| 101 | Ketoacidosis (HP:0001993) | 1.86868211 |
| 102 | Psychosis (HP:0000709) | 1.86716446 |
| 103 | Hypokalemia (HP:0002900) | 1.86438776 |
| 104 | Postural tremor (HP:0002174) | 1.86434338 |
| 105 | Double outlet right ventricle (HP:0001719) | 1.85050315 |
| 106 | Congenital malformation of the right heart (HP:0011723) | 1.85050315 |
| 107 | Dysmetria (HP:0001310) | 1.84528291 |
| 108 | Genetic anticipation (HP:0003743) | 1.84131810 |
| 109 | Osteomalacia (HP:0002749) | 1.83660498 |
| 110 | Impaired smooth pursuit (HP:0007772) | 1.82091601 |
| 111 | Pancreatic fibrosis (HP:0100732) | 1.82030193 |
| 112 | Hyperkalemia (HP:0002153) | 1.81801387 |
| 113 | Postural instability (HP:0002172) | 1.80801881 |
| 114 | Split foot (HP:0001839) | 1.80308794 |
| 115 | Inability to walk (HP:0002540) | 1.79583944 |
| 116 | Focal dystonia (HP:0004373) | 1.79141245 |
| 117 | Akinesia (HP:0002304) | 1.77753764 |
| 118 | Abnormality of midbrain morphology (HP:0002418) | 1.75895043 |
| 119 | Molar tooth sign on MRI (HP:0002419) | 1.75895043 |
| 120 | Hyperthyroidism (HP:0000836) | 1.75639363 |
| 121 | Retinal atrophy (HP:0001105) | 1.75545437 |
| 122 | Prolonged QT interval (HP:0001657) | 1.74962749 |
| 123 | Hyperaldosteronism (HP:0000859) | 1.74598522 |
| 124 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.73109489 |
| 125 | Scanning speech (HP:0002168) | 1.73038543 |
| 126 | Hypoplasia of the corpus callosum (HP:0002079) | 1.72835464 |
| 127 | Retinal dysplasia (HP:0007973) | 1.70624124 |
| 128 | Sleep apnea (HP:0010535) | 1.70606439 |
| 129 | True hermaphroditism (HP:0010459) | 1.70354475 |
| 130 | Lower limb muscle weakness (HP:0007340) | 1.69810967 |
| 131 | Thyroid-stimulating hormone excess (HP:0002925) | 1.68905834 |
| 132 | Paraplegia (HP:0010550) | 1.68353375 |
| 133 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.67592004 |
| 134 | Hypoventilation (HP:0002791) | 1.67251868 |
| 135 | Spastic tetraplegia (HP:0002510) | 1.65741672 |
| 136 | Acute encephalopathy (HP:0006846) | 1.65606125 |
| 137 | Fetal akinesia sequence (HP:0001989) | 1.65284546 |
| 138 | Oligodactyly (HP:0012165) | 1.65005879 |
| 139 | Congenital sensorineural hearing impairment (HP:0008527) | 1.64947988 |
| 140 | Neurofibrillary tangles (HP:0002185) | 1.64456477 |
| 141 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.64320511 |
| 142 | Abolished electroretinogram (ERG) (HP:0000550) | 1.64256959 |
| 143 | Abnormality of the diencephalon (HP:0010662) | 1.62584219 |
| 144 | Postaxial hand polydactyly (HP:0001162) | 1.62129173 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.21737015 |
| 2 | INSRR | 3.27093248 |
| 3 | MAP2K7 | 3.12128202 |
| 4 | MARK1 | 3.09930049 |
| 5 | CASK | 3.06249735 |
| 6 | MAP3K4 | 2.90595500 |
| 7 | MAP3K12 | 2.54405066 |
| 8 | MINK1 | 2.53588338 |
| 9 | TNIK | 2.19479138 |
| 10 | AKT3 | 2.13041002 |
| 11 | NTRK2 | 2.11047563 |
| 12 | MAP2K4 | 2.04321856 |
| 13 | PRKD3 | 2.03860386 |
| 14 | MAP3K9 | 1.91691236 |
| 15 | SIK3 | 1.88863642 |
| 16 | NTRK1 | 1.85849159 |
| 17 | MAP3K2 | 1.60322778 |
| 18 | PASK | 1.47522875 |
| 19 | UHMK1 | 1.45137336 |
| 20 | MAPK13 | 1.44159661 |
| 21 | HIPK2 | 1.40085285 |
| 22 | CSNK1G3 | 1.35901982 |
| 23 | WNK3 | 1.32244548 |
| 24 | CAMKK2 | 1.30026643 |
| 25 | TYRO3 | 1.26276680 |
| 26 | GRK5 | 1.26066734 |
| 27 | PNCK | 1.24934468 |
| 28 | PAK6 | 1.20694741 |
| 29 | BRAF | 1.20319021 |
| 30 | BMPR1B | 1.19887570 |
| 31 | PRKCG | 1.19049645 |
| 32 | CSNK1G1 | 1.18942864 |
| 33 | PRKCE | 1.18902328 |
| 34 | ARAF | 1.18864585 |
| 35 | CDK5 | 1.17889379 |
| 36 | FGFR2 | 1.16119483 |
| 37 | IRAK2 | 1.15506072 |
| 38 | WNK4 | 1.15126847 |
| 39 | EPHA4 | 1.14900293 |
| 40 | SIK2 | 1.13844959 |
| 41 | SGK2 | 1.13324819 |
| 42 | ERBB3 | 1.12205299 |
| 43 | MAP3K1 | 1.12053860 |
| 44 | MAP4K2 | 1.11049025 |
| 45 | SGK223 | 1.04602864 |
| 46 | SGK494 | 1.04602864 |
| 47 | STK16 | 1.02607213 |
| 48 | IRAK1 | 1.00823239 |
| 49 | MAP3K6 | 1.00615848 |
| 50 | RPS6KA2 | 0.98656230 |
| 51 | KSR1 | 0.97678157 |
| 52 | FRK | 0.96770988 |
| 53 | PRKCH | 0.95998180 |
| 54 | MUSK | 0.94928143 |
| 55 | CDC42BPA | 0.91245459 |
| 56 | PLK2 | 0.91203198 |
| 57 | CAMKK1 | 0.91003502 |
| 58 | TAOK3 | 0.90473583 |
| 59 | WNK1 | 0.88238670 |
| 60 | BCR | 0.87252598 |
| 61 | PRKCZ | 0.86113589 |
| 62 | PAK3 | 0.86069293 |
| 63 | CAMK2A | 0.86039789 |
| 64 | IRAK3 | 0.85774018 |
| 65 | ERBB4 | 0.85632194 |
| 66 | PHKG2 | 0.85259305 |
| 67 | PHKG1 | 0.85259305 |
| 68 | MAPK15 | 0.79411213 |
| 69 | RET | 0.78000729 |
| 70 | GRK1 | 0.76468678 |
| 71 | ADRBK1 | 0.75544736 |
| 72 | MKNK2 | 0.75309322 |
| 73 | ADRBK2 | 0.74646197 |
| 74 | BMPR2 | 0.73156019 |
| 75 | PRPF4B | 0.71909163 |
| 76 | CAMK1G | 0.71258419 |
| 77 | DYRK1A | 0.70911510 |
| 78 | FES | 0.68139607 |
| 79 | STK38 | 0.67088129 |
| 80 | STK11 | 0.66057710 |
| 81 | DAPK2 | 0.64698612 |
| 82 | GRK7 | 0.64639135 |
| 83 | NME1 | 0.64570050 |
| 84 | CAMK1 | 0.62732614 |
| 85 | CDK15 | 0.61174361 |
| 86 | OXSR1 | 0.60753524 |
| 87 | CSNK1G2 | 0.60568656 |
| 88 | CDK18 | 0.60094329 |
| 89 | ROCK2 | 0.59465736 |
| 90 | CAMK2B | 0.58829758 |
| 91 | SGK1 | 0.57082003 |
| 92 | KSR2 | 0.56862991 |
| 93 | FER | 0.56219253 |
| 94 | CAMK2D | 0.55944413 |
| 95 | STK38L | 0.55160431 |
| 96 | SGK3 | 0.54820158 |
| 97 | CDK11A | 0.52936722 |
| 98 | RPS6KB1 | 0.52792575 |
| 99 | MARK2 | 0.51805307 |
| 100 | DAPK1 | 0.51799693 |
| 101 | CAMK2G | 0.50854736 |
| 102 | LIMK1 | 0.50524266 |
| 103 | PRKACA | 0.48606820 |
| 104 | DYRK2 | 0.46832688 |
| 105 | TSSK6 | 0.46627852 |
| 106 | PINK1 | 0.46321401 |
| 107 | PKN1 | 0.44535473 |
| 108 | BCKDK | 0.44493070 |
| 109 | CAMK4 | 0.44368137 |
| 110 | NEK6 | 0.44140794 |
| 111 | TNK2 | 0.43760907 |
| 112 | CSNK1D | 0.43073110 |
| 113 | PRKG1 | 0.43039305 |
| 114 | RPS6KA3 | 0.42643353 |
| 115 | CDK19 | 0.41790627 |
| 116 | MAP3K5 | 0.41122085 |
| 117 | CSNK1A1 | 0.39293609 |
| 118 | PRKCA | 0.38988421 |
| 119 | MAPK10 | 0.38885738 |
| 120 | CSNK1A1L | 0.38357415 |
| 121 | ROCK1 | 0.38101077 |
| 122 | CDK14 | 0.37211682 |
| 123 | SCYL2 | 0.37039241 |
| 124 | PRKCB | 0.36694277 |
| 125 | MAP2K1 | 0.35831178 |
| 126 | PRKACB | 0.34929692 |
| 127 | TRIM28 | 0.34729198 |
| 128 | EPHB2 | 0.34525233 |
| 129 | CSNK1E | 0.33807077 |
| 130 | MAPK12 | 0.30610552 |
| 131 | PRKCI | 0.29467001 |
| 132 | CDK3 | 0.29216924 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.56030220 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.54717176 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 3.30422170 |
| 4 | Insulin secretion_Homo sapiens_hsa04911 | 2.70309340 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.68324524 |
| 6 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.55241584 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.45370033 |
| 8 | Taste transduction_Homo sapiens_hsa04742 | 2.42336163 |
| 9 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.25580186 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.24149337 |
| 11 | Protein export_Homo sapiens_hsa03060 | 2.23637341 |
| 12 | Circadian entrainment_Homo sapiens_hsa04713 | 2.08936260 |
| 13 | Long-term potentiation_Homo sapiens_hsa04720 | 1.96468673 |
| 14 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.94009666 |
| 15 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.90043577 |
| 16 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.88547319 |
| 17 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.87457967 |
| 18 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.85796324 |
| 19 | Olfactory transduction_Homo sapiens_hsa04740 | 1.84901510 |
| 20 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.82030997 |
| 21 | Cocaine addiction_Homo sapiens_hsa05030 | 1.77184814 |
| 22 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.74322499 |
| 23 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.73894003 |
| 24 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.70920308 |
| 25 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.62421100 |
| 26 | Long-term depression_Homo sapiens_hsa04730 | 1.57547612 |
| 27 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.51304462 |
| 28 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.38579287 |
| 29 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.34433243 |
| 30 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.32918772 |
| 31 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.28509404 |
| 32 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.26847396 |
| 33 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.26141432 |
| 34 | Salivary secretion_Homo sapiens_hsa04970 | 1.24287113 |
| 35 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.22975636 |
| 36 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.19924216 |
| 37 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.19873337 |
| 38 | Alzheimers disease_Homo sapiens_hsa05010 | 1.16050116 |
| 39 | Renin secretion_Homo sapiens_hsa04924 | 1.15309104 |
| 40 | Parkinsons disease_Homo sapiens_hsa05012 | 1.12944763 |
| 41 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.10918871 |
| 42 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.09948115 |
| 43 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.09462039 |
| 44 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.02255272 |
| 45 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.98099712 |
| 46 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.95928356 |
| 47 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.93862938 |
| 48 | Phototransduction_Homo sapiens_hsa04744 | 0.91586507 |
| 49 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.90305244 |
| 50 | Gap junction_Homo sapiens_hsa04540 | 0.89499789 |
| 51 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.88351431 |
| 52 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.88108155 |
| 53 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.87895963 |
| 54 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.87193892 |
| 55 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.83596160 |
| 56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.83459840 |
| 57 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.82337478 |
| 58 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.80827363 |
| 59 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.80480707 |
| 60 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.80405112 |
| 61 | Circadian rhythm_Homo sapiens_hsa04710 | 0.79845818 |
| 62 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.79139410 |
| 63 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.78687838 |
| 64 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.74693823 |
| 65 | Huntingtons disease_Homo sapiens_hsa05016 | 0.73918888 |
| 66 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.73269721 |
| 67 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.72613809 |
| 68 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.71465808 |
| 69 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.68356291 |
| 70 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.67784901 |
| 71 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.67515225 |
| 72 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.66397726 |
| 73 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.65995271 |
| 74 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.65868001 |
| 75 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.65805010 |
| 76 | Melanogenesis_Homo sapiens_hsa04916 | 0.65655622 |
| 77 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.63905251 |
| 78 | Phagosome_Homo sapiens_hsa04145 | 0.63819936 |
| 79 | Alcoholism_Homo sapiens_hsa05034 | 0.63055884 |
| 80 | Axon guidance_Homo sapiens_hsa04360 | 0.62933937 |
| 81 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.62857193 |
| 82 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.60008002 |
| 83 | Bile secretion_Homo sapiens_hsa04976 | 0.58941951 |
| 84 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.57892322 |
| 85 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.57738007 |
| 86 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.55498649 |
| 87 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.55330211 |
| 88 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.54808297 |
| 89 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.53077548 |
| 90 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.52678662 |
| 91 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.51905526 |
| 92 | Glioma_Homo sapiens_hsa05214 | 0.51761744 |
| 93 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.51328638 |
| 94 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.50363659 |
| 95 | Lysosome_Homo sapiens_hsa04142 | 0.49986178 |
| 96 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.48700907 |
| 97 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.48036226 |
| 98 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.46924365 |
| 99 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.46709546 |
| 100 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.45590336 |
| 101 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.45152675 |
| 102 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.44746636 |
| 103 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.41294807 |
| 104 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.39661455 |
| 105 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.39534350 |
| 106 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.38059569 |
| 107 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.37901386 |
| 108 | Prion diseases_Homo sapiens_hsa05020 | 0.37742724 |
| 109 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.37735993 |
| 110 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.37136028 |
| 111 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.37090760 |
| 112 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.37044513 |
| 113 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.36331301 |
| 114 | Peroxisome_Homo sapiens_hsa04146 | 0.35593026 |
| 115 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.35415495 |
| 116 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.35163768 |
| 117 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.34708016 |
| 118 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.34672104 |
| 119 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.33602869 |
| 120 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.33060459 |
| 121 | Endometrial cancer_Homo sapiens_hsa05213 | 0.32171088 |
| 122 | Other glycan degradation_Homo sapiens_hsa00511 | 0.31525852 |
| 123 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.31236271 |
| 124 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.29962852 |
| 125 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.26574819 |
| 126 | Melanoma_Homo sapiens_hsa05218 | 0.26549443 |
| 127 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.25704224 |

